Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 11392
TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611704(US11718609, Compound BT2120)
Affinity DataIC50: 700nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611704(US11718609, Compound BT2120)
Affinity DataIC50: 700nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611701(US11718609, Compound BT2062)
Affinity DataIC50: 1.00E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611708(US11718609, Compound BT2164)
Affinity DataIC50: 3.13E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611710(US11718609, Compound BT2169 | BDBM611716)
Affinity DataIC50: 3.30E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611723(US11718609, Compound BT2184)
Affinity DataIC50: 3.39E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611723(US11718609, Compound BT2184)
Affinity DataIC50: 3.39E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611725(US11718609, Compound BT2187)
Affinity DataIC50: 3.64E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611710(US11718609, Compound BT2169 | BDBM611716)
Affinity DataIC50: 4.00E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611725(US11718609, Compound BT2187)
Affinity DataIC50: 4.10E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611710(US11718609, Compound BT2169 | BDBM611716)
Affinity DataIC50: 4.30E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611708(US11718609, Compound BT2164)
Affinity DataIC50: 6.10E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611707(US11718609, Compound BT2162 | BDBM611714)
Affinity DataIC50: 6.70E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM50165652(2-(2-(4-(3-(4-bromophenyl)acrylamido)-3-fluorophen...)
Affinity DataIC50: 7.68E+3nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611718(US11718609, Compound BT2178)
Affinity DataIC50: 1.10E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611721(US11718609, Compound BT2181)
Affinity DataIC50: 1.10E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611726(US11718609, Compound BT2229)
Affinity DataIC50: 1.34E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611726(US11718609, Compound BT2229)
Affinity DataIC50: 1.34E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611712(US11718609, Compound BT2171)
Affinity DataIC50: 1.40E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611720(US11718609, Compound BT2179)
Affinity DataIC50: 1.80E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611722(US11718609, Compound BT2182)
Affinity DataIC50: 1.80E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611706(US11718609, Compound BT2161)
Affinity DataIC50: 1.89E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611705(US11718609, Compound BT2148)
Affinity DataIC50: 2.05E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611717(US11718609, Compound BT2177)
Affinity DataIC50: 2.10E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611724(US11718609, Compound BT2185)
Affinity DataIC50: 2.20E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611707(US11718609, Compound BT2162 | BDBM611714)
Affinity DataIC50: 2.26E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611707(US11718609, Compound BT2162 | BDBM611714)
Affinity DataIC50: 2.26E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611709(US11718609, Compound BT2167)
Affinity DataIC50: 3.30E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611657(US11718609, Compound BT2005)
Affinity DataIC50: 4.10E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611702(US11718609, Compound BT2090)
Affinity DataIC50: 5.36E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611711(US11718609, Compound BT2170)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611700(US11718609, Compound BT2057)
Affinity DataIC50: 5.60E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611698(US11718609, Compound BT2013)
Affinity DataIC50: 5.75E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent

TargetHeparanase(Human)
Beta Therapeutics

US Patent
LigandPNGBDBM611696(US11718609, Compound BT2007)
Affinity DataIC50: 9.27E+4nMAssay Description:Recombinant human active heparanase derived from Chinese hamster ovary cells was from R&D Systems. Bovine serum albumin-coated 96 well microplates (9...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
Go to US Patent